Actoplus Met [Actos and Metformin] Aug 2005
|
Actoplus Met is a combo of Actos and Metformin
According to Takeda Pharmaceutical Co. news release, U.S.
FDA has approved its new drug - Actoplus Met for diabetes
treatment and they plan to sell it in Octobor.
Actoplus Met is a single tablet of two existing diabete
drugs: Actos and metformin. Actos (pioglitazone HCl) is a
diabetes drug used to improve insulin resistance and
metformin is also a diabetes drug used to control the
glucose level produced by the liver.
Actoplus Met will have two strength-combinations: 15
mg/500 mg and 15 mg / 850 mg. Both are to be given once
daily or in divided doses not exceeding the maximum
recommended daily doses of pioglitazone 45 mg and
metformin 2,550 mg.
The new drug product may mean that type 2 diabetes
patients take one combo tablet instead of two tablets for
the treatment. However, there is also a chance that the
individual may need to take divided doses.
References
FDA approves new diabetes pill, Takeda's combination
medication approved by FDA is the company's second
approval this summer. CNN/Money Online Publcation,
August 29, 2005.
Nikkei recovers on Wall St gains, Toyota bought
Reuter India, India, Online Publication, August 29 2005.

THIS WEBSITE TALKS ABOUT THE SIDE EFFECTS AND THE POTENTIAL HEALTH BENEFITS OF HERBS, SUPPLEMENTS,
PHYTONUTRIENTS AND DRUG PRODUCTS. THIS WEBSITE ALSO TALKS ABOUT SOME POPULAR HEALTH ISSUES AND DISEASES.
ARTICLES IN THIS WEB SITE IS FOR YOUR REFERENCE ONLY. IF YOU HAVE ANY QUESTION, YOU SHOULD CONSULT WITH YOUR
DOCTOR IMMEDIATELY. ALL RIGHTS RESERVED 2008. DO NOT COPY NOR TRANSFER ARTICLES TO OTHER WEBSITES NOR OTHER
FORMS OF PUBLICATIONS. Privacy Policy. ARTICLE INDEX